tiprankstipranks
Advertisement
Advertisement

NVO Stock Latest News

Novo Nordisk Tests Cagrilintide in Patients Who Cannot Tolerate GLP-1 Weight-Loss Drugs
Company AnnouncementsNovo Nordisk Tests Cagrilintide in Patients Who Cannot Tolerate GLP-1 Weight-Loss Drugs
4d ago
NVO
Lexaria Bioscience ‘s human study GLP-1-H26-7 has begun dosing
PremiumThe Fly
Lexaria Bioscience ‘s human study GLP-1-H26-7 has begun dosing
4d ago
NVO
LEXX
Novo Nordisk Details Progress in DKK 15 Billion Share Buyback
PremiumCompany Announcements
Novo Nordisk Details Progress in DKK 15 Billion Share Buyback
5d ago
6K
NVO
Same Stock. Better Return. How STHH Quietly Outperformed STM Without Doing Anything Different
PremiumMarket News
Same Stock. Better Return. How STHH Quietly Outperformed STM Without Doing Anything Different
6d ago
BP
TM
CVS Health Stock Jumps as Pharmacy Expands Weight-Loss Offerings
PremiumMarket News
CVS Health Stock Jumps as Pharmacy Expands Weight-Loss Offerings
7d ago
CVS
LLY
Novo Nordisk Stock Climbs as Analyst Flags Potential for More Wegovy Pill Sales
PremiumMarket NewsNovo Nordisk Stock Climbs as Analyst Flags Potential for More Wegovy Pill Sales
10d ago
LLY
NVO
Novo Nordisk upgraded to Buy from Hold at Nordea
Premium
The Fly
Novo Nordisk upgraded to Buy from Hold at Nordea
10d ago
NVO
Novo Nordisk Stock Jumps as Owner Launches Obesity Research Network
Premium
Market News
Novo Nordisk Stock Jumps as Owner Launches Obesity Research Network
10d ago
LLY
NVO
After Novo Nordisk’s Oral Peptide Playbook Made History – Could Entera be The Next Big Peptide Story?
PremiumTipRanks Newswire
After Novo Nordisk’s Oral Peptide Playbook Made History – Could Entera be The Next Big Peptide Story?
11d ago
NVO
ENTX
Barclays Raises HIMS Stock Price Target on Strong GLP-1 Growth
PremiumMarket News
Barclays Raises HIMS Stock Price Target on Strong GLP-1 Growth
11d ago
NVO
HIMS
Hims & Hers price target raised to $39 from $29 at Barclays
PremiumThe Fly
Hims & Hers price target raised to $39 from $29 at Barclays
11d ago
NVO
HIMS
Palatin Technologies Is Pursuing the Next Generation of MC4R. Rhythm Just Reinforced Why That Matters
PremiumTipRanks Newswire
Palatin Technologies Is Pursuing the Next Generation of MC4R. Rhythm Just Reinforced Why That Matters
11d ago
LLY
NVO
Novo Nordisk’s Iraq Haemophilia Study Adds Real‑World Support for Turoctocog Alfa
PremiumCompany AnnouncementsNovo Nordisk’s Iraq Haemophilia Study Adds Real‑World Support for Turoctocog Alfa
12d ago
NVO
Moderately bullish activity in Novo Nordisk with shares up 1.96%
Premium
The Fly
Moderately bullish activity in Novo Nordisk with shares up 1.96%
12d ago
NVO
Novo Nordisk price target raised to DKK 325 from DKK 300 at Berenberg
Premium
The Fly
Novo Nordisk price target raised to DKK 325 from DKK 300 at Berenberg
12d ago
NVO
Novo Nordisk Seeks China Approval for Wegovy Pill, Intensifying Rivalry with Lilly
PremiumMarket News
Novo Nordisk Seeks China Approval for Wegovy Pill, Intensifying Rivalry with Lilly
13d ago
LLY
NVO
Novo Nordisk Expands 2026 Share Buyback, Holding 0.8% of Capital in Treasury Shares
PremiumCompany Announcements
Novo Nordisk Expands 2026 Share Buyback, Holding 0.8% of Capital in Treasury Shares
14d ago
6K
NVO
Eli Lilly Stock (LLY) Dips on Reports Employers Plan to Drop Weight-Loss Drug Coverage
PremiumMarket News
Eli Lilly Stock (LLY) Dips on Reports Employers Plan to Drop Weight-Loss Drug Coverage
17d ago
CI
LLY
Novo Nordisk announces security incident on ‘limited number’ of systems
PremiumThe Fly
Novo Nordisk announces security incident on ‘limited number’ of systems
18d ago
NVO
Novo Nordisk reports Wegovy pill approved in UK
PremiumThe FlyNovo Nordisk reports Wegovy pill approved in UK
18d ago
NVO
Employers considering dropping coverage of GLP-1 drugs in 2027, Reuters reports
Premium
The Fly
Employers considering dropping coverage of GLP-1 drugs in 2027, Reuters reports
18d ago
CI
LLY
Eli Lilly Stock (LLY) Jumps 4%. The Outlook for Its Weight-Loss Drugs Just Keeps Getting Better
Premium
Market News
Eli Lilly Stock (LLY) Jumps 4%. The Outlook for Its Weight-Loss Drugs Just Keeps Getting Better
21d ago
LLY
NVO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >